LSL Pharma Group Inc. secured $6.44 million in the first closing of non-brokered private placements to expand production capacity and for working capital purposes.
LSL Pharma Group Inc. announced the first closing on March 18, 2024 of non-brokered private placements for $6.44 million, out of the $8.0 million combined financings announced on March 7, 2024. The financing includes cash proceeds and the conversion of the Corporation’s debts into units for debts. The raised funds will be used to expand production capacity and for general working capital purposes.
Company Information
Company
LSL Pharma Group
Location
Boucherville, Quebec, Canada
About
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. . Leveraging its technical expertise, certified facilities, and experienced team, LSL Pharma delivers high-quality solutions that meet the highest industry standards. The companies that are part of the LSL Pharma Group are Steri-Med Pharma Inc., Laboratoire LSL Inc., Virage Santé Inc., Dermolab Pharma Ltd. and Laboratoire Du-Var Inc.
Fundz sees it the moment LSL Pharma Group raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BouchervilleManufacturingBiotechnologyHealth CarePharmaceuticalDietary Supplements